Hints and tips:
...The slate will include several former heads of healthcare giants: Ron Dollens, the former chief executive of Guidant, Dr Ernest Mario, former chief executive of Glaxo, Hank McKinnell, former chief executive...
...St Jude Medical rose 0.6 per cent to $53.83 on speculation that J&J would switch its attention to St Jude should it lose out on Guidant....
...Boston Scientific, which is working to close a $27bn acquisition of rival medical device maker Guidant, moved up 8.7 per cent after its finance chief bought up 200,000 shares of the company for $4.5m....
...Best’s purchase followed a sharp fall in Boston’s share price in recent weeks as investors expressed reservations over the group’s pending $27bn acquisition of rival medical device maker Guidant....
...Elsewhere, Johnson & Johnson’s $35bn takeover of Guidant, which makes cardiac stents, has put pressure on rival medical equipment suppliers....
...It follows Johnson & Johnson's planned $24bn acquisition of Guidant, the cardiac stent maker, and the pending $35bn merger between Sprint and Nextel, the telecommunications groups....
International Edition